Liver Resection and Local Ablation of Breast Cancer Liver Metastases—A Systematic Review
Surgical Options in Breast Cancer Liver Metastases
M Bergenfeldt, BV Jensen, B Skjoldbye, D Nielsen
Yes
20110601
2011 Jul 1
Eur J Surg Oncol
Liver Resection and Local Ablation of Breast Cancer Liver Metastases—A Systematic Review
Eur J Surg Oncol. 2011 Jul 1;37(7):549-557, M Bergenfeldt, BV Jensen, B Skjoldbye, D Nielsen
Abstract
Abstract
Aim: To analyze surgical treatment of breast cancer liver metastases (BCLM) regarding selection criteria, outcome and prognostic parameters. Methods: We searched Embase and Medline for all studies published 1999–2010.Results: Resection was associated with a median survival (MOS) of 20–67 months and 5-year survival of 21–61%. Local ablation also had a favorable outcome; MOS was 30–60 months and 5-year survival 27–41%. Regarding selection, no specific limits regarding the number and size of BCLM can...
